 Conference Call Scheduled for Thursday, June 30 at 11:30 AM EDT NORTHVALE, NJ ACCESSWIRE June 29, 2022 Elite Pharmaceuticals, Inc. Elite or the Company OTCQB:ELTP, a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year ended March 31, 2022 Fiscal 2022. Consolidated revenues for Fiscal 2022 were 32.3 million, an increase of 6.9 million or 27 as compared to the comparable period of the prior fiscal year. 